Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.25 AUD | +4.67% | +7.02% | -4.69% |
05:49am | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- MarketScreener Strategies